EYLEA HD
Wet AMD, diabetic macular edema
Phase 3Active
Key Facts
About Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a premier biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company has built a diversified portfolio of FDA-approved treatments and maintains a robust pipeline across oncology, immunology, ophthalmology, and other therapeutic areas. Regeneron's proprietary VelociSuite technologies, including VelocImmune mice and advanced manufacturing capabilities, enable rapid drug discovery and development. With multiple billion-dollar commercial products and strong financial performance, Regeneron ranks among the most successful biotech companies globally.
View full company profileTherapeutic Areas
Other Wet AMD, diabetic macular edema Drugs
| Drug | Company | Phase |
|---|---|---|
| Eylea (aflibercept) | Bayer | Approved |